← FDA DRUG APPROVALS

FDA ANDA · ANDA077222

FOSINOPRIL SODIUM

fosinopril

Sponsor: INVAGEN PHARMS

APPLICATION
ANDA077222
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-20
LATEST ACTION
2016-01-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FOSINOPRIL SODIUMPrescription
FOSINOPRIL SODIUM 20MG · TABLET · ORAL
FOSINOPRIL SODIUMPrescription
FOSINOPRIL SODIUM 40MG · TABLET · ORAL
FOSINOPRIL SODIUMPrescription
FOSINOPRIL SODIUM 10MG · TABLET · ORAL

Approval history

2016-01-26Labeling · Supplement 7 · standardAP
2016-01-26Labeling · Supplement 5 · standardAP
2005-04-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →